Updated February 19, 2017. There's no right way to study in college. Even students who have the same majors and take the same classes won't need to spend the same amount of time on coursework, because everyone has their own way of learning.
The advent of a new class of drugs known as biologics has revolutionized the treatment of rheumatoid arthritis (RA). These drugs, which include Cimzia, Enbrel, Humira, Kineret, Orencia, Remicade, Rituxan, and Simponi, must be given via self-injection or intravenous infusion in the doctorâs office or hospital. They also can be expensive and are not always covered by insurance.
The U.S. Food and Drug Administration (FDA) recently approved Praluent (alirocumab)â and Repatha (evolocumab)â, the first cholesterol-lowering injection treatments in the new class of PCSK9 inhibitors. Theyâre designed to be used in combination with statin therapy and dietary changes. Praluent and Repatha are for adults with heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL cholesterol in the blood, and those with clinical cardiovascular disease.